The Impact of Social Responsibility and Innovation Ecosystem of Chinese Pharmaceutical Enterprises on Innovation Performance

Abstract

This article studies how corporate social responsibility affects the innovation performance of pharmaceutical companies from the perspective of the innovation ecosystem. Based on a large amount of theoretical evidence, we have proposed hypotheses about the constituent dimensions of key factors and their impact on relationships. We constructed a measurement scale for corporate social responsibility, resource acquisition, synergy, and innovation performance from measurement projects, expert interviews, interviewee interviews, and pre surveys. Large scale formal research provided data, and regression analysis confirmed the hypothesis. Out of 11 research hypotheses, 9 were validated by data, 1 was not validated, and 1 was partially supported. And its effectiveness and ineffectiveness were tested. Summarized the document and provided suggestions to the management. Pharmaceutical companies can improve innovation performance by fulfilling social responsibility, and the support of the innovation ecosystem mediates the causal relationship between corporate social responsibility and innovation performance. Innovation ecosystem support mainly includes resource acquisition and collaborative symbiosis. The focus of innovation ecosystem support is on synergy and resource acquisition. Corporate social responsibility and innovation performance are linked through resource acquisition and synergy.